Brightspring Health Services, Inc. key statistics and ratios
In fiscal 2025, Brightspring Health Services, Inc. had return on equity of 10.8%, an operating margin of 2.3%, debt equal to 137.0% of equity and a current ratio of 1.57. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|
| Gross margin | 17.5% | 14.8% | 12.6% | 11.8% | 12.5% |
| Operating margin | 2.4% | 0.8% | 1.1% | 2.3% | 3.4% |
| Net margin | −0.7% | −2.0% | −0.2% | 1.5% | 2.7% |
| Free-cash-flow margin | −1.0% | 1.8% | −0.6% | 3.1% | 3.2% |
| Return on equity | −7.1% | −23.1% | −1.6% | 10.8% | 20.3% |
| Return on assets | — | −2.8% | −0.3% | 3.1% | 6.5% |
| Asset turnover | — | 1.39 | 1.76 | 2.09 | 2.41 |
| Current ratio | — | 1.17 | 1.33 | 1.57 | 1.62 |
| Debt to equity | — | 583.9% | 162.8% | 137.0% | 102.8% |
| Interest cover (operating income ÷ interest) | 0.8x | 0.2x | 0.6x | 1.9x | 3.6x |
| Effective tax rate | — | — | — | 24.0% | 17.1% |
| SG&A as % of revenue | 14.6% | 14.1% | 11.5% | 9.5% | 9.1% |
| Capital spending as % of revenue | 0.9% | 1.0% | 0.8% | 0.7% | 0.7% |
| Free cash flow ÷ net income | — | — | — | 207.0% | 120.0% |
| Dividends and buybacks ÷ free cash flow | — | 0.5% | — | 10.9% | — |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 18.2% | 11.8% | 11.9% | 11.8% | 11.6% | 13.3% | 12.7% | 12.3% |
| Operating margin | 3.0% | 1.8% | 1.5% | 2.6% | 3.0% | 3.4% | 3.4% | 3.8% |
| Net margin | 0.9% | 1.0% | 0.9% | 1.7% | 2.2% | 4.1% | 2.2% | 2.4% |
| Free-cash-flow margin | 4.1% | 2.9% | 0.8% | 2.8% | 5.5% | 2.8% | 0.4% | 4.3% |
| Current ratio | 1.33 | 1.73 | 1.76 | 1.79 | 1.57 | 1.74 | 1.59 | 1.62 |
| Debt to equity | 158.4% | 150.4% | 145.1% | 138.4% | 133.7% | 126.2% | 106.9% | 100.3% |
| SG&A as % of revenue | 15.2% | 10.0% | 10.4% | 9.1% | 8.6% | 10.0% | 9.4% | 8.5% |
Financial health
- Short-term assets cover short-term liabilities $2.8bn of assets due within a year against $1.7bn of liabilities due within a year.
- Short-term assets cover long-term liabilities $2.8bn short-term assets against $2.4bn of longer-dated liabilities.
- More cash than debt $718m of cash against $2.2bn of debt.
- Debt below 40% of shareholders' equity Debt is 100% of equity.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt $603m of operating cash flow against $2.2bn of debt.
- Operating profit covers interest at least five times over Operating income of $520m against $145m of interest.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Compare with peers
- Labcorp statistics
- DaVita statistics
- Quest Diagnostics statistics
- Agilon Health, Inc. statistics
- Option Care Health, Inc. statistics
Head to head: BTSG vs LHBTSG vs DVABTSG vs DGX
More: Health Care Services stocks compared, Health Care sector, rankings of US companies